Q&A: Obesity Medicine 2026 Will Emphasize ‘Treating the Whole Picture’

Why It Matters

By uniting clinicians around integrated cardiometabolic strategies, the conference accelerates adoption of evidence‑based obesity treatments, directly impacting patient outcomes and industry innovation.

Key Takeaways

• Conference runs April 10‑12 in San Diego
• Theme emphasizes whole‑picture cardiometabolic obesity care
• Keynote by nutrition expert Frank Hu, MD, PhD
• Advanced cases cover bariatric revisions, fatty liver, osteoarthritis
• All sessions recorded, accessible via OMA Academy

Pulse Analysis

The 2026 Obesity Medicine conference arrives at a pivotal moment as U.S. obesity prevalence hovers near 42 percent, driving unprecedented demand for comprehensive care models. By branding the meeting “The Heart of Obesity Care,” the Obesity Medicine Association signals a shift from siloed disease management toward a unified cardiometabolic framework. This perspective recognizes that heart disease, type 2 diabetes, and non‑alcoholic fatty liver disease often coexist, and treating obesity can simultaneously mitigate each condition, offering clinicians a more efficient therapeutic roadmap.

Program highlights reflect the rapid evolution of obesity therapeutics. Attendees will explore the latest GLP‑1 receptor agonist data, practical physical‑activity prescription tools, and cutting‑edge nutrition research presented by Frank Hu, a leading authority on dietary variability. The “Advanced Cases” track delves into complex scenarios such as bariatric surgery revisions, metabolic‑associated steatotic liver disease, and obesity‑related osteoarthritis, providing seasoned practitioners with actionable insights. By blending pharmacologic advances with behavioral and lifestyle strategies, the conference equips providers to deliver personalized, multi‑modal treatment plans.

Beyond education, the event’s broader impact lies in shaping market dynamics and policy discussions. Industry partners gain real‑time feedback on pipeline candidates, while clinicians return to practice armed with concrete skills to improve patient outcomes from day one. Recorded sessions on the OMA Academy extend the conference’s reach, ensuring that even non‑attendees can stay current on best practices. Collectively, these elements reinforce obesity medicine’s transition from niche specialty to mainstream, high‑impact component of American health care.